Apatinib, a novel tyrosine kinase inhibitor, suppresses tumor growth in cervical cancer and synergizes with Paclitaxel-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Apatinib, a novel tyrosine kinase inhibitor, suppresses tumor growth in cervical cancer and synergizes with Paclitaxel

Published:2018-05-19 Issue:10 Volume:17 Page:1235-1244
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Qiu Haifeng¹,Li Jing²,Liu Qiuli³,Tang Mei³,Wang Yuan³

Affiliation:

1. Department of Obstetrics and Gynecology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

2. Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

3. Department of Obstetrics and Gynecology, the Affiliated Hospital of Jiangnan University, Wuxi, China

Funder

National Natural Science Funds

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384101.2018.1471315

Reference20 articles.

1. Cancer statistics in China, 2015

2. Global cancer statistics, 2012

3. Developments in the systemic treatment of metastatic cervical cancer

4. YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo

5. Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polyethylene glycol-mediated functionalization of nanodelivery systems for improving their pharmacokinetic profile and anticancer efficacy;International Journal of Polymeric Materials and Polymeric Biomaterials;2024-07-30

2. Small molecule inhibitors of the VEGF and tyrosine kinase for the treatment of cervical cancer;Medical Oncology;2024-07-10

3. SULF1 Activates the VEGFR2/PI3K/AKT Pathway to Promote the Development of Cervical Cancer;Current Cancer Drug Targets;2023-08-04

4. Mechanism of Apatinib gene carried with carbon nanotube in regulating the growth and chemosensitivity of human papilloma virus through inducing AMPK/TSC2/mTOR signal pathway;Materials Express;2023-07-01

5. SULF1 promotes malignancy potential of cervical cancer by activating VEGFR2/PI3K/AKT signaling pathway;2023-06-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3